Publications & Research


Peer review publications in journals

  1. R. Basuroy, R. Srirajaskanthan, J.K Ramage. A multimodal approach to the management of neuroendocrine tumour liver metastases. International journal of hepatology, in press

  2. S. Sofroniadou, T. Kassimatis, R. Srirajaskanthan, J. Reidy, D. Goldsmith. Long-term safety and efficacy of renin-angiotensin blockade in atherosclerotic renal artery stenosis. Int. Uro Nephrol, in press.

  3. R. Srirajaskanthan, D. Vallini. Azathioprine induced hepatitis in patients with inflammatory bowel diease. International Journal of Clinical Pharmacy, 2011

  4. R.Srirajaskanthan, S.Easdale. Novel imaging techniques in management and diagnosis of neuroendocrine tumours. J Surg Oncol. 2011, 33(5):724-5

  5. R. Srirajaskanthan, K. Agarwal, J. Karanyi. Massive gastrointestinal bleed in patient with primary sclerosing cholangitis. Gastroenterology, 2011 140(5):e7-8

  6. R. Srirajaskanthan, D. Shanmugabavan, J.K Ramage. Easily missed. Carcinoid syndrome. BMJ, 2010; 341:603-4.

  7. S. Soni, R. Srirajaskanthan, S. Alexander, S.B Lucas, T. Wong, and J.A White Lymphogranuloma venereum proctitis masquerading as inflammatory bowel disease in 12 homosexual men. Alimentary, Pharmacology and Therapeutics, 2010; 32:59-65.

  8. R. Srirajaskanthan, I. Kayani, J. Soh, A.M Quigley, M.E Caplin, J. Bomanji . The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumours and negative or equivocal 111In-DTPA-octreotide scintigraphy. Journal of Nuclear medicine, 2010; 51:875-82.

  9. R. Srirajaskanthan, M.E Caplin, M.G Waugh, J. Watkins, J.J Hsuan, N. Beaumont. Identification of Mac-2BP as a putative marker of neuroendocrine tumours from the analysis of cell line secretomes. Molecular and Cellular Proteomics, 2010; 9:656-66.

  10. R. Srirajaskanthan, R. Conn, C. Bulwer, P. Irving. The Blatchford scoring system enables accurate risk stratification of patients with upper gastrointestinal haemorrhage. International Journal of Clinical Practice, 2010; 64:868-74.

  11. R. Srirajaskanthan, T. Shah, J. Watkins, L. Marelli, A. Quaglia, K. Khan, R. Sim, D. Hochhauser, M.E Caplin. The expression ErB family of receptors in Neuroendocrine Tumours. Oncology reports. 2010; 23: 909-15.

  12. P.A Berry, R. Srirajaskanthan, S.H Anderson. An urgent call to the MR scanner – potential dangers of capsule endoscopy. Clin Gastroenterol Hepatol. 2009, 2010; 8(5):26.

  13. C. Toumpanakis, D.J Hochhauser, L. Marelli, R. Srirajaskanthan, J. Soh, P. Davies, J. Buscombe, M.E Caplin.  Long term results of patients with malignant carcinoid syndrome receiving Octreotide LAR. Alimentary Pharmacology & Therapeutics, 2009. 30(7):733-40.

  14. R. Srirajaskanthan, G. Dancy, A. Hackshaw, M.E Caplin, T. Meyer. Circulating Angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis. Endocrine related cancer, 2009. 16(3):967-76

  15. R. Srirajaskanthan, C. Toumpanakis, T. Meyer, M.E Caplin Review article: Future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours. Alimentary Pharmacology & Therapeutics. 2009 1; 29:1143-54.

  16. R. Srirajaskanthan, L. Marelli, A. Karpathakis, C. Toumpanakis, T. Meyer, J. Buscombe, M.Dusmet, M.E.Caplin. Bronchial carcinoid tumours: Clinical features and management in a series of 45 patients. Lung cancer. 2009; 65:68-73.

  17. R. Srirajaskanthan, J. Watkins, L. Marelli, M.E Caplin. Co-expression of somatostatin and dopamine receptors in neuroendocrine tumours, an immunohistochemical study. Neuroendocrinology 2009; 89:308-14.

  18. R. Srirajaskanthan, M. McStay, C. Toumpanakis, T. Meyer, M.E Caplin. Parathyroid hormone related peptide (PTHrP) secreting pancreatic neuroendocrine tumours: case series and literature review. Neuroendocrinology. 2009; 89:48-55.

  19. T Shah, R Srirajaskanthan, M Bhogal, C Toumpanakis, T Meyer, A Noonan, C Witney-Smith, T Amin, P Bhogal, N Sivathasan, B Warner, D H, M.E Caplin. Alpha fetoprotein and human chorionic gonadotrophin-β are prognostic tumour markers in patients with neuroendocrine tumours. British Journal of Cancer; 99:72-7.

  20. R. Srirajaskanthan, C. Toumpanakis, M. Dusmet, M.E Caplin. A review of thymic tumours. Lung cancer. 2008; 60:4-13.

  21. T. Shah, I. Kulakiene, V.S Warbey, A.M Quigley, R. Srirajaskanthan, C. Toumpanakis, D. Hochhauser, J. Buscombe, M.E Caplin. The role of 99mTechnetium-depreotide in the management of neuroendocrine tumours. Nucl Med Commun. 2008; 29:436-40.

  22. M.C.Y. Wong, B. Portmann, R. Sherwood, O. Niemela, H. Koivisto, S. Parkkila, K. Trick, M.R L’Abbe ,J. Wilson, P.R Dash, R. Srirajaskanthan, V.R Preedy, H. Wiseman. The cytoprotective effect of alpha-tocopherol and daidzein against D-galactosamine-induced oxidative damage in the rat liver. Metabolism; 2007 56:865-75.

  23. R. Srirajaskanthan, V.R Preedy. Alcohol as a toxic and disease forming agent: Not just the liver and brain and not every drinker. Journal of Nutritional and Environmental Medicine. 2007; 17 (2): 1-13.

  24. R. Srirajaskanthan, P. Hanek, D. Tripathi, P. Mairs. An obscure cause of gastrointestinal bleeding. Gastroenterology Today, 2007 17(1): 19-21.

  25. R. Srirajaskanthan, V.R Preedy. Diagnosis and management of Alcoholic liver disease. Clinical effectiveness in Nursing  2006; 9:280-285

  26. Biochemical markers of alcoholism and their clinical effectiveness. R. Srirajaskanthan, V.R Preedy. Clinical effectiveness in nursing 2006; 9 sup 3: 280-285

  27. R. Srirajaskanthan, T. Winter, AF. Muller Thrombosis in inflammatory bowel disease. European Journal of Gastroenterology and Hepatology. 2005; 17:697-700.

  28. B. Afalzi, R.S Bakri, R. Srirajaskanthan, A. Covic, P. Bharma-Ariza, W. Park, M. Sriharan, N. Dalton, A. Wierzbicki, M. Crook,  D.G Goldsmith. Elevated plasma sialic acid in renal transplant patients with cardiovascular disease. Clinical Transplantation 2004; 18:201-204.

  29. R. Srirajaskanthan, D.G Goldsmith. Atherosclerotic renal artery stenosis-the challenge of patient mortality. Journal of renovascular disease 2003: 2; 3-9.